The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a move reflecting growing international interest in Gulf healthcare assets, Brookfield Asset Management and other private equity firms are considering the acquisition of Fakih IVF. According to reports, the potential deal could value the company at approximately $1 billion, as it is considered one of the most prominent fertility clinic operators in the region. These discussions emerge as the healthcare sector demonstrates significant resilience despite regional geopolitical tensions.
Sign in to access this content
Sign InThis interest aligns with global private equity trends targeting specialized healthcare sectors in emerging markets, following several similar regional transactions. Per market data, the estimated $1 billion valuation would place this deal among the largest acquisitions in the specialized medical services sector this year. Analysts suggest that Brookfield is looking to strengthen its portfolio in markets experiencing rising demand for advanced healthcare services.
Regarding market performance, BAM shares stood at $44.15 (close May 21, 2026) as investors await official confirmation of the deal. Market participants are monitoring Canada's Retail Sales data scheduled for release on May 22, 2026, as a potential sentiment driver, alongside any updates regarding the financing structure of this major acquisition which could reshape the regional fertility services landscape.